Fundraising FoxTheraheart
Irvine, US · Founded 2023 · Delaware corporation · 1 known investors
Find your way into Theraheart
Sign up to see every warm intro you have to Theraheart
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Theraheart team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Theraheart is a medical device manufacturer developing minimally invasive technologies to treat heart failure patients. The company designs its products with the needs of patients and medical professionals in mind.
Founders & leadership
WG
Wei GanChief Executive OfficerWei Gan is Executive Officer and Director at Theraheart, a medical device manufacturer developing minimally invasive technologies for heart failure treatment. He brings expertise in interventional cardiology.
Board
Investors · 1
Qiming Venture PartnersreportedBeijing
How we know: a partner's Signal profile · castleplacement.com · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$11.6M disclosed across 1 round · 2025
▶$11.6MraisedOct 2025 · 9 investors · OtherRule 506(b)
▶$11.6MraisedOct 2025 · 9 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Sheng WangDirector
- Wei GanExecutive Officer, Director
- Rani MahmoudiDirector
- Offering amount
- $20.6M
- Amount sold
- $11.6M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
SyncardiaSynCardia manufactures the world's first commercially approved total artificial heart for patients with end-stage heart failure awaiting transplant. The company develops and delivers mechanical circulatory support devices as alternatives to heart transplantation for critically ill patients.
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Aviary HealthAviary Health provides virtual and hybrid clinical programs — including cardiac rehabilitation, pulmonary rehabilitation, and chronic care management — combining AI-powered workflows with clinical teams. It serves hospitals and health systems, delivering end-to-end support for complex service lines.
InnovHeartInnovHeart develops the Saturn Transcatheter Mitral Valve Replacement (TMVR) system, a trans-septal mitral valve bioprosthesis used in interventional cardiology to treat mitral valve disease. The company is a medical device maker focused on structural heart interventions for cardiac patients.
Edwards LifesciencesEdwards Lifesciences develops innovative medical technologies for treating cardiovascular disease, focusing on structural heart interventions. The company serves patients and healthcare providers globally through partnerships with clinicians and healthcare stakeholders.
Companies working in the same space as Theraheart.
Frequently asked questions
- What does Theraheart do?
- Theraheart is a medical device manufacturer developing minimally invasive technologies to treat heart failure patients. The company designs its products with the needs of patients and medical professionals in mind.
- Who are Theraheart's investors?
- Theraheart's investors include Qiming Venture Partners.
- How much funding has Theraheart raised?
- Theraheart has disclosed $11.6M raised across 1 round.
- Where is Theraheart headquartered?
- Theraheart is headquartered in Irvine, US.